´ëÇѽÅÀåÇÐȸ (¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà) Á¦1Â÷ ½Å¼ººóÇ÷¿¬±¸È¸ ¿¬¼ö°Á : 2021-01-23±³À°ÀÏÀÚ : 2021-01-23
±³À°Àå¼Ò : ¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà (*¿ÀÇÁ¶óÀÎ: °æ±âµµ ¾È¾ç / ÇѸ²´ëÇб³¼º½Éº´¿ø ½Ã¹Ä·¹ÀÌ¼Ç ¼¾ÅÍ )
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà) Á¦1Â÷ ½Å¼ººóÇ÷¿¬±¸È¸ ¿¬¼ö°Á ÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ½Å¼ººóÇ÷¿¬±¸È¸
´ã´çÀÚ : ÀÓ¼±È
¿¬¶ôó : 031-380-3976
À̸ÞÀÏ :
karai.secretary@gmail.com ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 500¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
°æ±âµµ±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 20,000¿ø
ºñ°í Àü¹®ÀÇ 20,000¿ø / ÀüÀÓÀÇ, °£È£»ç 10,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 01¿ù 23ÀÏ ½Ã¹Ä·¹ÀÌ¼Ç ¼¾ÅÍ 09:15~09:50 HIF-prolyl hydroxylase inhibitors in renal anemia ±è¼º±Õ(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 01¿ù 23ÀÏ ½Ã¹Ä·¹ÀÌ¼Ç ¼¾ÅÍ 09:50~10:25 ESA treatment in anemia management ȲÇö¼®(°æÈñÀÇ´ë)
Åä·Ð 01¿ù 23ÀÏ 10:25~10:35 Q&A ()
±³À°½Ã°£ 01¿ù 23ÀÏ ½Ã¹Ä·¹ÀÌ¼Ç ¼¾ÅÍ 10:50~11:20 effect of anemia on outcome in ESRD °íÀºÁ¤(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 01¿ù 23ÀÏ ½Ã¹Ä·¹ÀÌ¼Ç ¼¾ÅÍ 11:20~11:50 Effect of online hemodiafiltration on anemia Á¤ÇýÀ±(ºÐ´çÂ÷º´¿ø)
±³À°½Ã°£ 01¿ù 23ÀÏ ½Ã¹Ä·¹ÀÌ¼Ç ¼¾ÅÍ 11:50~12:20 Usefulness of mid-week hemoglobin measurement ±èÈ¿»ó(¿ï»êÀÇ´ë)
Åä·Ð 01¿ù 23ÀÏ 12:20~12:30 Q&A ()